1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CINGULATE INC
Cingulate Inc
XNAS: CING
Download real time
5.290.06(1.15%)
55.51% Fall from 52W High
32,823.9
XNAS Volume

XNAS 22 Sep, 2026 11:37 AM (EDT)

Portfolio

Alert

My Notes

Cingulate Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Cingulate Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • NEUTRAL

    Quarterly Revenue Cingulate Inc Jun-2026 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • NEGATIVE

    Quarterly Net Profit Cingulate Inc Jun-2026 Quarterly Net Profit is $-6 Million which is growth of -22.6% YoY.

Cingulate Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
Cost Of Rev.
-------------
Gross Profit
-------------
⌄
5.47.95.664.73.76.23.33.236.85.86.4
Operating Profit
-5.4-7.9-5.6-6-4.7-3.7-6.2-3.3-3.2-3-6.8-5.8-6.4
⌄
-0.1-0.5-0.6-0.6-0.1-0.10.10.1-0-0.1-0.2-0.3
Profit Before Tax
-5.9-9.3-6.3-7.3-4.8-3.8-6.1-3.2-3.2-3-6.9-6-6.6
Tax
⌄
-5.9-9.3-6.3-7.3-4.8-3.8-6.1-3.2-3.2-3-6.9-6-6.6
Diluted NI Avail to Com Stockholders Ann.
-5.9-9.3-6.3-7.3-4.8-3.8-6.1-3.2-3.2-3-6.9-6-6.6
Basic EPS
-0.5-1-0.9-1.4-1.1-1-1.8-1.8-5.5-7.2-71.3-72-136.8
Diluted EPS After ExtraOrdinary
-0.4-0.9-0.9-1.2-1.1-1-1.8-1.8-5.5-7.2-71.3-72-136.8
Number Of Shares End
13.29.86.75.44.43.73.41.80.60.40.10.10.1
Net Income Continuing Discontinued Operations
-5.9-9.3-6.3-7.3-4.8-3.8-6.1-3.2-3.2-3-6.9-6-6.6
Normalized Income
-5.6-8.5-6.1-6.6-4.8-3.8-6.1-3.2-3.2-3-6.9-6-6.6
Interest Income
-------------
Interest
-------------
Net Interest Income
-0.1-0.5-0.6-0.6-0.1-0.10.10.1-0-0.1-0.2-0.3
EBIT
-5.4-7.9-5.6-6-4.7-3.7-6.2-3.3-3.2-3-6.8-5.8-6.4
EBITDA
-5.3-7.8-5.5-5.9-4.5-3.5-6.1-3.1-3-2.8-6.6-5.6-6.2
Reconciled Cost Of Rev.
-------------
Reconciled Depr.
0.10.10.10.10.20.20.20.20.20.20.20.20.2
Profit From Continuing Operations
-5.9-9.3-6.3-7.6-4.8-3.8-6.1-3.2-3.2-3-6.9-6-6.6
Normalized EBITDA
-5-7-5.3-5.1-4.5-3.5-6.1-3.1-3-2.8-6.6-5.6-6.2
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Cingulate Inc competitor comparison and performance snapshot within industry

Cingulate Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEUTRAL

    Annual Revenue Cingulate Inc Annual Revenue is $0 Million which is growth of 0% YoY.

  • NEGATIVE

    Annual Net Profit Cingulate Inc Annual Net Profit is $-22 Million which is growth of -44.4% YoY.

Cingulate Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19
⌄
-
-
 
Cost Of Rev. Ann.
-
-
 -------
Gross Profit Ann.
-
-
 -------
Operating Exp. Ann.
4.4%
22.9%
24.919.915.722.817.520.77.111.7
Operating Profit Ann.
-
-
-24.9-19.9-15.7-22.8-17.5-20.7-7.1-11.7
⌄
-
-
-1.8-1.40.1-0.8-0.2-0-0.10.1
Other Exp. Ann.
-
-
 -1.2------
PBT Ann.
-
-
-28.8-22.5-15.6-23.5-17.7-20.7-7.2-11.6
Tax Ann.
-
-
 --
⌄
-
-
-28.8-22.5-15.6-23.5-17.7-20.7-7.2-11.6
Diluted NI Avail to Com Stockholders Ann.
-
-
-28.8-22.5-15.6-23.5-17.7-20.7-7.2-11.6
EPS Ann.
-
-
 -4.4-10.2-312-374.4-669.6-152.4-245
Diluted EPS Ann.
-
-
 -4.4-10.2-312-374.4-669.6-152.4-245
Number Of Shares End
306.2%
131.9%
 6.73.40.10.10.10.1-
Total Exp. Ann.
4.4%
22.9%
 19.915.722.817.520.77.111.7
Net Income Continuing Discontinued Operations Ann.
-
-
-28.8-22.5-15.6-23.5-17.7-20.7-7.2-11.6
Normalized Income Ann.
-
-
-26.7-21.3-15.6-23.5-17.7-20.7-7.2-11.6
Interest Income Ann.
-
-
 -------
Interest Ann.
-
-
 -------
EBITDA Ann.
-
-
-24.5-19.4-15-22.2-17.1-20-6.4-11.5
Reconciled Cost Of Rev. Ann.
-
-
 -------
Reconciled Depr. Ann.
7.7%
-6.5%
0.40.50.70.60.40.70.70.2
Profit From Continuing Operations Ann.
-
-
-29-22.5-15.6-23.5-17.7-20.7-7.2-11.6
Normalized EBITDA Ann.
-
-
-22.4-18.3-15-22.2-17.1-20-6.4-11.5
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Operating Exp. Ann.
1Y CHG
26.8%
2Y CAGR
-6.6%
3Y CAGR
4.4%
5Y CAGR
22.9%

Cingulate Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Total Shareholders Fund Cingulate Inc Dec-2025 Total Shareholders Fund is $3 Million which is growth of -66.3% YoY.

  • POSITIVE

    Total Assets Cingulate Inc Dec-2025 Total Assets is $15 Million which is growth of 1.4% YoY.

Cingulate Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19
⌄
9.8%
21.1%
15.114.93.511.422.95.85.3
⌄
18.9%
22.9%
12.67.410.47.524.54.7
⌄
-13.8%
14%
2.57.5-6.93.920.81.30.6
Total Capitalization Ann.
-1.7%
23.3%
3.79.9-6.93.920.81.30.6
Tangible Assets Ann.
-13.8%
14%
2.57.5-6.93.920.81.30.6
Working Capital Ann.
23.6%
-
1.77.7-9.70.917.7-1.6-2
Invested Capital Ann.
4%
40.9%
1012.4-3.98.920.81.80.6
Tangible Book Value Ann.
-13.8%
14%
2.57.5-6.93.920.81.30.6
Borrowings Ann.
17%
33.2%
8.85.13.55.50.92.12.1
Net Debt Ann.
-
-
--3----
Share Issued Ann.
317.9%
135.9%
7.33.40.10.10.10.10.1
Number Of Shares End
306.2%
131.9%
6.73.40.10.10.10.1-
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
1.3%
2Y CAGR
107.7%
3Y CAGR
9.8%
5Y CAGR
21.1%
Total Current Liabilities Ann.
1Y CHG
106%
2Y CAGR
0.5%
3Y CAGR
13.7%
5Y CAGR
24.8%
Total ShareHolders Funds Ann.
1Y CHG
-66.7%
3Y CAGR
-13.8%
5Y CAGR
14%

Cingulate Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Book Value Per Share Cingulate Inc Book Value Per Share is $2 which is growth of 62.2% YoY.

  • NEUTRAL

    ROE Cingulate Inc ROE is 0% which is growth of 0% YoY.

Cingulate Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19
RoA Ann. %
-
-
--169.38%-315.98%-103.09%-144.45%-129.80%-218.65%
ROE Ann. %
-
-
--5,305.02%--142.98%-187.12%-752.88%-1,874.76%
ROIC %
-
-
--49.4--39.4-20.3-35.8-
OPM Ann. %
-
-
-------
Inventory Turnover Ratio Ann.
-
-
-------
Asset Turnover Ann. %
-
-
-------
Working Capital Turnover Ann.
-
-
Quick Ratio Ann.
-
-
-2.500.814.60.40.2
Current Ratio Ann.
-
-
-2.60.11.116.10.50.3
Interest Coverage Ratio Ann.
-
-
-------
LT Debt To Equity Ann.
-
-
-0.3-0.100.92.8
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Cingulate Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Cash From Operating Activity Cingulate Inc Cash From Operating Activity is $-17 Million which is growth of 6.5% YoY.

  • NEGATIVE

    Net Cash Flow Cingulate Inc Net Cash Flow is $-1 Million which is growth of -110.3% YoY.

Cingulate Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19
⌄
-
-
-17.3-18.5-15-15.9-10.4-6.8-9.5
⌄
-
-
-0.2-0.2-0.2-0.2-0.8-0.42.7
⌄
49%
15.2%
16.230.8104.926.586.1
Cash Plus Cash Eqv. End Of Year Ann.
26.8%
55.8%
1112.20.15.416.51.20.4
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-1.312.2-5.3-11.115.30.8-0.6
Cash Plus Cash Eqv. Begin Of Year Ann.
-9.6%
98.1%
12.20.15.416.51.20.41.1
Income Tax Paid Supplemental Data Ann.
-
-
-------
Interest Paid Supplemental Data Ann.
-
-
00000.10.1
Capex Ann.
-
-
-0.2-0.2-0.2-0.2-0.8-0.4-1
Issuance Of Capital Stock Ann.
-
-
10.225.9720.4--
Issuance Of Debt Ann.
6.3%
43.1%
65351
Repayment Of Debt Ann.
-
-
-0-0-0-0.9-0.5
Repurchase Of Capital Stock Ann.
-
-
-------
Free Cash Flow Ann.
-
-
-17.4-18.7-15.3-16-11.3-7.2-10.6
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Financing Act. Ann.
1Y CHG
-47.4%
2Y CAGR
27.3%
3Y CAGR
49%
5Y CAGR
15.2%
×